SUMOylation-Driven Subtype Heterogeneity and Prognostic Biomarkers in Renal Cell Carcinoma
Xiaobo Zhang, Zhiming Li, Ruoxin Lin, Suping Yang, Xiaohui Sun, Shicheng Chen · 2026
Read SUMOylation-Driven Subtype Heterogeneity and Prognostic Biomarkers in Renal Cell Carcinoma by Xiaobo Zhang, Zhiming Li, Ruoxin Lin, Suping Yang, Xiaohui Sun, Shicheng Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13511082.txt.
Description
Xiaobo Zhang, Zhiming Li, Ruoxin Lin, Suping Yang, Xiaohui Sun, and Shicheng Chen study genes tied to a tagging process called SUMOylation in kidney cancer, in 2026 work. In this process, small tags attach to proteins and change their behavior. Kidney cancers vary widely at the molecular level, yet care guidance leans on one subtype and leaves others less served. The team hunted for tag-linked genes whose activity differs in tumors.
They found 298 such genes, with 151 tied to kidney cancer itself rather than to subtype quirks. Ten core genes stood out, and one of them separated tumor from normal tissue while also telling the main subtype apart from two rarer ones, a possible second-step marker. A six-gene risk model predicted survival well inside single subtypes, though pooling subtypes weakened its accuracy. The authors say subtype variety itself limits shared prediction tools.
Catalog record
| CREATOR | Xiaobo Zhang, Zhiming Li, Ruoxin Lin, Suping Yang, Xiaohui Sun, Shicheng Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |